TOP STORIES

• COMMENTARY MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
  September 8, 2025

• BUSINESS And Pharma Chief Pledges Growth Strategy as New Generics Holding Firm Takes Shape
  September 5, 2025

• ORGANIZATION JPMA ICH Project Chair Sees RWE as Potential Complement to Clinical Trials
  September 5, 2025

• BUSINESS Bayer Pushes Cross-Border Open Innovation with New Co.Lab Connect Program
  September 4, 2025

• ORGANIZATION JPMA Regulatory Chief Seeks Balanced Approach on Japanese PI Waivers
  September 3, 2025

• REGULATORY Pharma Groups Press Pricing Reform at First Public-Private WG Meeting
  September 2, 2025

• REGULATORY Japan Panel Clears Izervay, Nexletol for Approval; Eylea Biosimilars Edge Ahead Too
  September 1, 2025

• REGULATORY METI Proposes “Bold Investment” Tax Breaks in FY2026 Request
  September 1, 2025

• REGULATORY Japan Panel Green Lights Nonprescription Switch of Morning-After Pill
  September 1, 2025

• REGULATORY MHLW Orders Label Revision for Elevidys to Add Acute Hepatic Failure
  September 1, 2025

• ORGANIZATION Indicators Needed to Frame Pharma as Growth Market in Japan, Says JPMA Policy Chief
  August 29, 2025

• REGULATORY Japan to Expand List of “Stable Supply Medicines” to 759 APIs, Adding Vaccines and Blood Products
  August 28, 2025

• COMMENTARY Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
  August 27, 2025

• REGULATORY MHLW Pharma Bureau Seeks FY2026 Budget to Bolster PMDA and Speed Up SaMD Reviews
  August 27, 2025

• REGULATORY MHLW Seeks New R&D Tax Credit Scheme for Strategic Technologies in FY2026 Proposal
  August 27, 2025

• REGULATORY Japan Approves 3 New Drugs, Expands Label for Enhertu, Silgard 9 and More
  August 26, 2025

• BUSINESS Meiji Revives Penicillin Raw Material Production in Japan after 31 Years, Races to Pass Down Know-How
  August 26, 2025

• BUSINESS Astellas CFO Outlines Cost Cuts, Licensing Push as Xtandi Nears Patent Cliff
  August 25, 2025

• REGULATORY Novartis’ Radioligand Therapy, More Meds Inch Closer to Japan Approval with Panel OK
  August 25, 2025

• REGULATORY PMDA’s “Early Considerations” Start to Pay Off with Faster Reviews
  August 22, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• …
• Next ›
• 最終 »